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Abstract: 
L-Proline derived spirolactams and -methyl prolinamides act as organocatalysts for 
the asymmetric conjugate addition of aldehydes to nitroolefins in excellent yields, 
with good diastereoselectivity and enantioselectivity. Furthermore, low catalyst 
loadings (5 mol%) and a low aldehyde molar excess (1.5 molar equivalents) were 
achieved. 
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Introduction 
 
The field of organocatalysis has seen an explosion of interest in the last decade.
1
 In 
particular, L-proline derived compounds have found use as organocatalysts in the 
asymmetric Michael addition reaction of aldehydes and ketones to nitroolefins, with 
the products being produced in high yields, with excellent diastereo- and 
enantioselectivities (Figure 1).
1-6
 However, in many earlier cases either a large excess 
of the aldehyde or ketone is required (10-20 molar equivalents) or high levels of 
catalysts (10-25 mol%). More recently highly efficient catalyst systems for this 
transformation have been developed and are the benchmark for all new catalysts. Ma 
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was able to achieve high yields and selectivities using only 0.5 mol% of 4 and 1.5 
equivalents of aldehyde in the presence of benzoic acid as an additive.
3
 However, 
Lombardo recently reported the use of the ion-tagged diphenylprolinol silyl ether 7 
which achieves enantiomeric excesses of >99.5% at low catalyst loadings (0.25-5 
mol%), and uses only a slight excess of aldehydes (1.2-2 molar equivalents).
4
 The 
most efficient catalyst reported to-date is the tripeptide 8 described by Wennemers.
5
 
This catalyst is highly efficient at levels of only 0.1-0.2 mol%, even with the 
nitroalkene in excess, giving high yields and selectivities for a range of aldehydes and 
nitroalkenes. The usefulness of the products from these reactions resides in the 
potential for further transformation of both the nitro and carbonyl functionalities.  
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Figure 1. Proline and 4-hydroxyproline derived organocatalysts.
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There is an ongoing requirement for the development of new organocatalysts for this 
and other important chemical transformations, in order to fully understand the 
structure-reactivity relationships of these catalysts. Many of the reported proline-
derived catalysts are conformationally flexible in nature and it was thought that the 
introduction of conformational constraints into the structure could lead to more 
specific catalysts, which might allow the use of lower amounts of aldehyde or ketone, 
along with the requirement for low levels of the organocatalyst (e.g. 5% or less). One 
way to introduce such conformational constraint would be to have, for example, the L-
4 
 
proline as part of a rigid spiro fused ring system. Royer recently prepared such a rigid 
pyrrolidino spiro diamine (9, Figure 1) and it exhibited limited success in its ability to 
act as an asymmetric organocatalyst in the Michael addition reaction of aldehydes to 
nitroolefins, although only one set of reaction conditions was reported.
6
 Rather than 
having the second amino group as an exocyclic substituent, incorporation of the 
second nitrogen atom as part of the ring would give spirolactam and spirodiamine 
structures. 
 
Results and Discussion 
 
As part of a program to synthesise both enantiomerically pure and racemic proline-
derived [4.4]-spirolactams, we recently reported our studies on their preparation by 
thermal intramolecular ester aminolysis methods.
7
 Diastereoisomeric spirolactams 
(11a and 11b) were prepared and separated chromatographically (Figure 2).  
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Figure 2. Synthesised spirolactam and spirodiamine organocatalysts 
 
It was also found that the spiro diamine derivatives 13a and 13b complexed a zinc 
ion.
7c
 Although the stereochemistry of the -methyl benzyl substituent was known, 
from the choice of the starting amine, the absolute stereochemistry of the spiro centre 
in each of the diastereoisomers was not known. Previously, we were unable to grow 
crystals of sufficient quality for X-ray analysis to be obtained, so NMR spectroscopy 
5 
 
along with molecular modelling
7c
 was used to tentatively assign the stereochemistry 
of the SR and RR diastereoisomeric pair, 11a and 11b. Eventually crystals of 
sufficient quality were obtained of 11b, by crystallisation from hexane, and an X-ray 
crystal structure was obtained (Figure 3), which confirmed the previous NMR 
spectroscopic and modelling assignments.
7b,c
  
 
Figure 3. Perspective view of 11b showing 50% probability ellipsoids. Hydrogen 
atoms omitted for clarity. 
 
The X-ray crystal structure clearly shows the R absolute stereochemistry at the spiro 
centre. As a result of this structure, the absolute stereochemistry of both 
diastereoisomers was now known. Treatment of 11a and 11b with trifluoroacetic acid 
gave the desired deprotected compounds 12a and 12b. An examination of the 
structures of these compounds shows that they can be considered as conformationally 
constrained analogues of prolinamides, an important class of organocatalysts. 
Therefore the investigation of the use of spirolactams 12a and 12b as organocatalysts 
in the model reaction of valeraldehyde with trans--nitrostyrene was undertaken 
(Table 1).  
 
Table 1. Michael addition reaction of valeraldehyde to -nitrostyrene. 
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H
n-Pr
O
+
Ph
NO2
H
n-Pr
O Ph
NO2
Catalyst
72 h
16  
 
Entry Solvent Cat Add Loading 
(mol%) 
Aldehyde 
(mol eq.) 
Temp. Yield
a
 dr
b
 ee
c
 
1 DCM 12a - 5 1.5 RT 98 62:38 66 
2 CHCl3 12a - 5 1.5 RT 98 65:35 65 
3 i-PrOH 12a - 5 1.5 RT 98 67:33 45 
4 THF 12a - 5 1.5 RT 43 74:26 80 
5 DMSO 12a - 5 1.5 RT 80 74:26 25 
6 DCM 12a - 5 1.5 4 77 70:30 76 
7 DCM 12a - 5 10 RT 90 73:27 80 
8 DCM 12a - 20 10 RT 98 64:36 72 
9 DCM 12b - 5 1.5 RT 98 67:33 63
d
 
10 CHCl3 12b - 5 1.5 RT 96 65:35 68
d
 
11 i-PrOH 12b - 5 1.5 RT 72 68:32 63d 
12 DCM 12b TFA 5 1.5 RT 71 60:40 53d 
13 DCM 15a - 5 1.5 RT 98 62:38 32 
14 DCM 15b - 5 1.5 RT 98 71:29 56
d
 
 
a
 Isolated yield after chromatography 
b
 Syn:anti ratio determined by 
1
H NMR spectroscopy 
c
 e.e. of syn isomer determined by chiral HPLC 
d 
Opposite enantiomer of the syn product 
 
The first reaction was conducted using a low molar excess of valeraldehyde (1.5 
equivalents) in dichloromethane at room temperature for 72 h in the presence of 5 
mol% of (S,R)-spirolactam 12a (entry 1). Product 16 was isolated in 98% yield, with a 
syn:anti ratio of 62:38, and the enantiomeric excess (e.e.) of the syn isomer was 66%. 
Changing the solvent to chloroform or 2-propanol gave similar results, while the use 
of THF as solvent gave a better syn:anti ratio of 74:26 and an e.e. of 80% for the syn 
isomer, although the isolated yield was much reduced at 43% (entries 2, 3 and 4). 
DMSO gave an 80% yield, with a syn:anti ratio of 74:26, but a poor e.e. of only 25% 
(entry 5). For further studies, DCM was used as solvent. The effect of temperature on 
the outcome of the reaction was examined by running the reaction at 4 
o
C (entry 6). In 
this case, the isolated yield was reduced to 77%, while the syn:anti ratio improved to 
70:30, with the syn isomer having an improved e.e. of  76%, when compared to the 
reaction at room temperature. Increasing the amount of valeraldehyde to 10 molar 
equivalents surprisingly gave a slight reduction in isolated yield to 90%, when 
compared to the use of 1.5 molar equivalents (98%, entry 1), but with an improved 
syn:anti ratio of 73:27, and an e.e. of 80% for the syn isomer (entry 7). Repeating this 
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reaction with 20 mol% of the catalyst, brought the isolated yield back to 98%, but 
unfortunately, the syn:anti ratio reduced to 64:36, with a concomitant reduction in the 
e.e. of the syn isomer to 72% (entry 8).  
 
Use of the diastereoisomeric (R,R)-spirolactam 12b as catalyst, under the standard 
conditions, gave similar isolated yields to those obtained with 12a, with similar 
syn:anti ratios (Entries 9, 10 and 11). The enantiomeric excesses were also similar 
but, most importantly, in these cases the opposite enantiomer of the syn 
diastereoisomer now predominated, as shown by chiral HPLC analysis. Other groups 
have observed an improvement in both the diastereoisomeric ratio and the e.e. of the 
syn isomer on the addition of acidic additives, such as trifluoroacetic acid (TFA). 
Addition of 1 molar equivalent of TFA, using spirolactam 12b as catalyst, gave a 
reduced isolated yield, with poorer diastereocontrol (Entry 12). All of these results 
show that it is the absolute stereochemistry of the spiro centre which is controlling the 
observed enantioselectivity, with the stereochemistry of the side-chain substituent 
having little effect. This is not surprising if the proposed transition state models of the 
reactions are considered (Figure 4).  
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Figure 4. Proposed transition state model for Michael addition reaction of 
valeraldehyde with -nitrostyrene using spirolactam catalysts. 
 
The syn diastereoselectivity observed is due to the “Seebach acyclic synclinal 
model”,8 in which there are favourable electrostatic interactions in the transition state 
between the enamine nitrogen and the nitro group. For the syn diastereoisomeric pair 
the Re face of the nitrostyrene can approach the enamine Re face in two different 
9 
 
ways (Re,Re-1 and Re,Re-2, Figure 4), depending on whether it approaches from the 
same, or opposite, side as the lactam carbonyl group. Similarly the Si face of the nitro 
styrene can approach enamine Si face in two ways (Si,Si-1 and Si,Si-2). Of the two 
possible Re,Re trajectories Re,Re-2 is the much more likely because there are two 
destabilising steric interactions present in the Re,Re-1 trajectory, namely the less 
favourable enamine rotamer as well as the interaction of the nitrostyrene with the 
lactam carbonyl group. Neither of these interactions are present in the Re,Re-1 
trajectory. Of the two possible Si,Si trajectories Si,Si-1 has the favourable enamine 
rotamer but a steric interaction with the lactam carbonyl, while Si,Si-2 has a steric 
interaction with the methylene of the lactam ring, as well as being the less favoured 
enamine rotamer. It is therefore not apparent which of these trajectories is more 
favoured. Overall, it is thus the contribution of favourable electrostatic interactions as 
well as the unfavourable steric interactions which controls the observed 
diastereoselecetivity and enantioselectivity. In the case of the use of the spirolactam 
12b as catalyst, with the opposite stereochemistry at the spirocentre, the transition 
state with the Si,Si approach of the faces of the -nitrostyrene and the enamine would 
be the predominant pathway, thus giving the observed (R,S) enantiomer as the major 
product.  
 
Increasing the steric bulk of the spirolactam side-chain was achieved by replacing the 
phenyl group with the 1-naphthyl group. The spirolactams were synthesised in an 
analogous manner to the phenyl substituted compounds,
7c
 but (R)-(1)-(1-
naphthyl)ethylamine was used in place of (R)-(1)-phenylethylamine. As before the 
two diastereoisomeric spirolactams, 14a and 14b, were separable. Their 
stereochemistries were tentatively assigned by comparison of their NMR spectral data 
(chemical shifts and coupling constants) with the phenyl-derived compounds, as well 
as their relative polarities as measured by TLC analysis. Use of the Boc deprotected 
compounds 15a or 15b in the Michael addition reaction gave similar yields and 
diastereoselectivities to those of the corresponding phenyl derivatives 12a and 12b, 
but with slightly lower enantioselectivities (Table 1, entries 13 and 14). This confirms 
that the lactam side-chain is having little effect on the stereochemical outcome of the 
reaction. 
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The scope of the catalysts (12a and 12b) was examined by reacting different 
aldehydes and -nitrostyrenes under the optimised conditions (Table 2). 
Propionaldehyde showed poor diastereo- and enantioselectivity (d.r. 62:38, e.e. 34%) 
and a reduced isolated yield of 77% (entry 1), while the more hindered iso-
valeraldehyde showed excellent diastereocontrol (d.r. 89:11) and a hugely improved 
e.e. of 82% (entry 2). Unfortunately, the isolated yield was poor (22%) due to the 
increased steric effect of the branched aldehyde. Reaction of valeraldehyde with 
substituted -nitrostyrenes show similar diastereo- and enatioselectivity to the parent 
-nitrostyrene (entries 3-8). The reason for the very poor enantioselectivity of catalyst 
12b (4% e.e.) with the para-methoxy substituted -nitrostyrene (entry 6) is not 
known. 
 
Table 2. Michael addition reaction of aldehydes to -nitrostyrenes 
 
H
R1
O
+
Ar
NO2
H
R1
O Ar
NO2
Catalyst (5 %)
DCM, RT, 72 h
 
 
Entry Cat R
1
 Ar Yield
a
 dr
b
 ee
c
 
1 12b Me Ph 77 62:38 34 
2 12b i-Pr Ph 22 89:11 82 
3 12a n-Pr p-tolyl 94 60:40 54 
4 12b n-Pr p-tolyl 90 63:37 62d 
5 12a n-Pr p-MeOC6H4 86 56:44 78 
6 12b n-Pr p-MeOC6H4 82 57:43 4
d
 
7 12a n-Pr p-ClC6H4 90 55:45 51 
8 12b n-Pr p-ClC6H4 92 62:38 73
d
 
 
Reactions carried out with 1.5 molar equivalents of aldehyde. 
a
 Isolated yield after chromatography 
b
 Syn:anti ratio determined by 
1
H NMR spectroscopy 
c
 e.e. of syn isomer determined by chiral HPLC 
d 
Opposite enantiomer of the syn product 
 
Many of the reported catalysts used to catalyse the Michael addition reaction of 
aldehydes and ketones to nitroolefins have been diamines derived from L-proline 
(Figure 1).
1,2,6
 For comparison, spirodiamines 13a and 13b were prepared, from 
spirolactams 12a and 12b, by removing the Boc group and reducing the lactam ring to 
the cyclic amine with lithium aluminium hydride.
7c
 When 13a was used as a catalyst 
11 
 
in the Michael addition reaction similar syn:anti ratios were obtained, to those when 
the corresponding spirolactams were used, though the isolated yield was only 85% 
(Table 3, entry 1).  
 
Table 3. Michael addition reaction of valeraldehyde to -nitrostyrene catalysed by 
diamines 13a and 13b. 
 
H
n-Pr
O
+
Ph
NO2
H
n-Pr
O Ph
NO2
Catalyst
 
 
Entry Cat Additive Loading 
(mol%) 
Aldehyde 
(mol eq.) 
Yield
a
 dr
b
 ee
c
 
1 13a - 5 1.5 85 65:35 2 
2 13b - 5 1.5 85 68:32 14
d
 
3 13a - 20 10 98 67:33 2 
4 13a TFA 5 1.5 99 61:39 3 
5 13a HCl 5 1.5 99 62:38 0 
6 13b TFA 5 1.5 98 65:35 3
d
 
 
Reactions carried out in DCM at ambient temperature, for 72 hours. 
 
a
 Isolated yield after chromatography 
b
 Syn:anti ratio determined by 
1
H NMR spectroscopy 
c
 e.e. of syn isomer determined by chiral HPLC 
d 
Opposite enantiomer of the syn product 
 
In these cases, however, the enantioselectivity was severely reduced, with the syn 
isomer now being obtained in close to racemic form. Increasing the amount of catalyst 
to 20 mol% only increased the isolated yield back to 98%, with no effect on the 
stereoselectivity of the reaction (entry 3). The addition of TFA or HCl as an additive, 
or using the epimeric spiro diamine 13b, had no effect on this outcome (entries 2, 4, 5 
and 6). The selectivity of substituted pyrrolidine-based organocatalysts in the Michael 
addition reaction is mostly determined by the nature of the substitutent in the 2-
position (trans-4-hydroxy substitutents also exert control).
1j
 For substituents with a 
hydrogen bond donor present (e.g. COOH in L-proline or the N-H in prolinamides and 
sulfonamides), it is the attractive interaction with the nitro group of the styrene and 
the hydrogen bond donor which controls the facial selectivity.
1a,1j
 In the absence of 
such hydrogen bond donors the facial selectivity is controlled by the steric effect of 
12 
 
the pyrrolidine side-chain. In this study, there is no hydrogen bond donor present in 
the spirolactams and thus the facial selectivity is as described previously. The results 
with the diamines 13a and 13b can be explained by examining the transition state 
model of the reaction (Figure 4). In the absence of the lactam carbonyl group the 
Re,Re-2 and Si,Si-1 trajectories are equally likely, since there is now a methylene 
attached to both sides of the quaternary spiro carbon. This leads to equal steric 
preference for the Re,Re-2 and Si,Si-1 trajectories and thus racemic products are 
obtained. In this case although the spiro diamine is more conformationally flexible, 
the bulky nitrogen side-chain is too remote from the spiro centre to have any impact 
on the stereocontrol.  
 
It would be envisaged that either breaking the lactam ring to give more 
conformational flexibility (17) or removal of the spiro fusion completely, to give 
simple prolinamides 18, might lead to improvements in the observed stereocontrol 
(Figure 5).  
 
N
N
H O
R
N
N
H O
R
17 18
R = H, Me R = H, Me
 
Figure 5. Conformationally flexible spirolactam analogues. 
 
For direct comparison with the spirolactam studies it was decided to keep the -
methyl benzylamine sidechains. The synthesis of the two sets of four stereoisomers of 
17 (R = Me or H) started from N-Boc-L-proline methyl ester 19 (Scheme 1).  
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Scheme 1: Reagents and conditions; (a) i) LiHMDS, THF, -78 oC, ii) methyl iodide, rt, 72%; 
(b) i) NaOH, MeOH/H2O, reflux,  ii) 1M HCl, 93%; (c) (R)-N,-dimethylbenzyl amine, DIPEA,
HATU, DMF, rt, 49%;  (d) 50% TFA in DCM, rt, 88-92%; (e) (R)--methylbenzyl amine, DIPEA, 
HATU, DMF, rt, 94%; (f) 50% TFA in DCM, rt, 93-96%.
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-Methylation of 19 with methyl iodide gave the racemic -methyl ester 20 in 72% 
yield, which was hydrolysed to the -methyl carboxylic acid 21, in 93% yield. The 
racemic acid was then coupled, separately with R- or S-N,-dimethylbenzylamine, 
using HATU as the coupling agent, to give the four N-methylated diastereoisomeric 
-methyl prolinamides (22a-d). 21 was also coupled, separately, with R- or S--
methylbenzylamine, under similar conditions, to give the four N-H stereoisomeric -
methyl prolinamides (22e-h). Removal of the Boc group in each of the eight 
compounds gave the free amines 17a-h. The relative stereochemistry of each 
compound was obtained from X-ray crystal structure data. Only one compound from 
each set gave crystals suitable for X-ray analysis (Figure 6).  
14 
 
 
17b (R,R) 
 
 
22g (R,S) 
 
 
Figure 6. X-ray structures of the cation of 17b and one of the two independent 
conformations of 22g. Both structures are drawn with 50% probability ellipsoids. 
Tosyl anion in 17b has been omitted for clarity. 
 
Since the stereochemistry of the amine side-chain was known, from the choice of 
amine starting material, the absolute stereochemistry of the quaternary centre was 
easily obtained. The crystalline side-chain N-H compound was obtained as its Boc 
derivative 22g (R,S stereochemistry) while the side-chain N-Me compound was 
obtained as its ammonium tosylate salt (17b.TsOH, R,R stereochemistry). 
 
15 
 
The simple L-prolinamides 18 were prepared from L-proline by Boc protection of the 
proline nitrogen, to give N-Boc-L-proline 23,  in almost quantitative yield, followed 
by separately coupling to R- or S--methylbenzylamine, to give the two 
diastereoisomeric prolinamides 24a and 24b (Scheme 2, only reaction with (R)--
methylbenzylamine to give 24a is shown).  
N COOMe
Boc
b
19
N COOH
Boc 23
N
H
N
Boc O
a
d
N
H
N
H O
N
N
Boc O
d
N
N
H O
Me Me
24a 18a
25a 18c
Scheme 2: Reagents and conditions; (a) i) NaOH, MeOH/H2O, reflux,  ii) 1M HCl, 98%;
(b) (R)--methylbenzyl amine, DMAP, EDC, DCM, rt, 90%; (c) i) LiHMDS, THF, -78 oC,
 ii) methyl iodide, rt, 92%;  (d) 50% TFA in DCM, rt, 86-91%.
c
 
 In these cases, efficient coupling was achieved using EDC, whereas HATU was 
necessary in the more sterically hindered coupling reactions above. N-methylation of 
24a (or 24b), with methyl iodide, gave the N-methyl prolinamide 25a (or 25b). 
Deprotection of 24a and 24b gave the N-H L-prolinamides 18a and 18b (R = H), 
while deprotection of 25a and 25b gave the N-Me L-prolinamides 18c and 18d (R = 
Me). Prolinamides 18a and 18b are known and have previously been described by 
Chimni as efficient organocatalysts, as their HBr salts, for the direct aldol reaction in 
water.
9
 Earlier Wu and Gong also described their use as enantioselective catalysts for 
direct aldol reactions.
10
 
 
The -methyl prolinamides 17a, 17b, 17e and 17f and simple prolinamides 18a-d 
were then examined as organocatalysts in the standard reaction (Table 4).  
 
 
Table 4. Michael addition reaction of valeraldehyde to -nitrostyrene catalysed by 
17a, 17b, 17e, 17f and 18a-d. 
 
16 
 
H
n-Pr
O
+
Ph
NO2
H
n-Pr
O Ph
NO2
Catalyst
 
 
Entry Catalyst Yield
a
 dr
b
 ee
c
 
1 17a (S,R) 98 61:39 40 
2 17b (R,R) 98 62:38 59
d
 
3 17e (S,R) 55 56:44 63 
4 17f (R,R) 60 56:44 59 d 
5 18a (S,R) 98 77:23 71 
6 18b (S,S) 98 98:2 81 
7 18c (S,R) 98 93:7 49 
8 18d (S,S) 94 94:6 65 
 
Reactions carried out in DCM with 1.5 molar equivalents of aldehyde, at ambient 
temperature, for 48 hours. 
 
a
 Isolated yield after chromatography 
b
 Syn:anti ratio determined by 
1
H NMR spectroscopy                     
c
 e.e. of syn isomer determined by chiral HPLC 
d 
Opposite enantiomer of the syn product 
 
The N-methyl--methyl compounds 17a and 17b gave very similar overall results to 
those obtained for the corresponding spirolactams 12a and 12b, with similar 
diastereocontrol but a slight decrease in enantioselectivity (entries 1 and 2). It is very 
important to note that the major syn enantiomer (16 (R,S)) obtained for 17a is 
opposite to that obtained with the spirolactam 12a (Figure 2). The -methyl N-H 
compounds 17e and 17f showed similar stereoselectivity, but surprisingly much 
reduced isolated yields of 55% and 60%. The reason for these reduced yields is not 
known, at present. These results clearly demonstrate that the presence of a proline -
substitutent is detrimental to achieving high levels of stereocontrol. This was borne 
out when the -hydrogen N-Me catalysts 18c and 18d were examined. With the 
removal of the -methyl substituent the isolated yield was brought back to 94-98% 
with excellent diastereoselectivity (~94:6). Unfortunately, there was no observed 
increase in enantioselectivity (entries 7 and 8). Finally, the two N-H catalysts 18a and 
18b were examined and found to give excellent isolated yields, diastereoselectivity 
and hugely improved enantioselectivity (71 and 81% e.e.). The diastereoselectivity for 
these two catalysts are quite different (77:23 and 98:2) and since both contain an N-H 
in the side-chain this difference is likely to be due to the overall conformation of the 
17 
 
side-chain (entries 5 and 6). Although 18b gave excellent yield and 
diastereoselectivity results, the enantiomeric excess was 81%, which is below the 
levels reported for many proline-derived catalysts.
3-5
 For this reason studies on the 
expansion of the scope of these catalysts in the Michael addition reaction with 
different aldehydes and substituted -nitrostyrenes were not undertaken. The 
proposed transition state model, involves a steric interaction between the nitro styrene 
and the amide side-chain on position 2 of the pyrrolidine which destabilises the Re,Re 
approach for these catalysts (Figure 7), even though there is a favourable electrostatic 
interaction between the nitro group and the enamine nitrogen. Thus the Si,Si approach 
predominates where there is a favourable electrostatic interaction between the nitro 
group and the enamine nitrogen, but no steric interaction with the amide side-chain, 
thus giving the R,S enantiomer of 16 as the major enantiomer. The selectivity 
observed is regardless of whether the side-chain contains an N-H, as a potential 
hydrogen bond donor for a favourable electrostatic interaction with the nitro group, or 
whether it is N-methylated. 
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Figure 7. Proposed transition state model for Michael addition reaction of 
valeraldehyde with -nitrostyrene using simple prolinamide catalysts 18a-d. 
 
From these studies, it is therefore apparent that the absence of an -substituent and 
the presence of a sufficiently bulky prolinamide are necessary for the optimal simple 
prolinamide organocatalyst, for the Michael addition reaction of aldehydes to -
nitrostyrenes. 
 
Conclusions 
 
In conclusion, the main advantage of the spirolactam and -methyl prolinamide 
organocatalysts used in this study is that both epimers of the -centre can be easily 
synthesised from a common starting material, L-proline. It is thus possible to 
selectively form either enantiomer of the syn Michael addition product, in excellent 
yield with good stereocontrol. In the case of other proline-derived catalysts, this 
would only be possible by separately preparing catalysts starting with D-proline. 
Furthermore, the amount of catalyst required for activity is low (5 mol%), along with 
the requirement of only 1.5 molar equivalents of the aldehyde partner. As stated 
previously the presence of a trans-4-hydroxy substitutent can have a considerable 
effect on the stereoselectivity obtained and we are also currently preparing analogues 
of all the synthesised organocatalysts reported here with this functionality present. 
Further studies on the scope of use of these new organocatalysts in the Michael 
addition reaction and other important asymmetric transformations are being 
undertaken, the results of which will be reported in due course. 
 
Experimental. 
 
TLC was performed on Merck silica gel 60F254 plates and column chromatography 
was performed on Aldrich silica gel, 70-230 mesh, 60Å. 
1
H and 
13
C NMR ( ppm; J 
Hz) spectra were recorded on a Jeol JNM-LA300 FT-NMR spectrometer using CDCl3 
solutions with Me4Si as internal reference, unless otherwise indicated, with 
resolutions of 0.18 Hz and 0.01 ppm, respectively. CHCl3 was used to remove last 
traces of ethyl acetate from some samples. The last trace of CHCl3 persisted even 
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after prolonged heating in vacuo and in these cases was visible in NMR spectra. 
Infrared spectra (cm
-1
) were recorded as KBr discs or liquid films between NaCl 
plates using a Nicolet Impact 410 FT-IR. Melting points were obtained on a Bibby 
Stuart Scientific SMP1 melting point apparatus. Microanalyses were carried out at the 
Microanalytical Laboratory of University College Dublin. High Resolution Mass 
spectra were obtained in the Centre for Synthesis and Chemical Biology, School of 
Chemistry and Chemical Biology, University College Dublin. X-ray crystal structures 
were obtained in the Chemistry Department, Loughborough University, 
Loughborough, UK. Chiral HPLC analysis were carried out using on a Shimadzu 
HPLC system Class-VP, incorporating a LC-10AD pump, SPD-M10AVP Diode 
Array Detector, Auto-injector SIJ-10A with a system controller SCL-10A VP, on 
Chiralcel OD-H and AD-H chiral columns. Polarimetry was carried out using an 
Optical Activity AA-55 series polarimeter at ambient temperature with a 2 dm, 1 ml 
cell. ()-2-Methyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (20) is 
commercially available but was synthesised (vide infra). 
 
N-Boc-L-proline methyl ester (19).
11
 
19 was prepared from L-proline by the method of Confalone
11
 giving 19 as a clear oil. 
Analytical data was in agreement with that reported. Microanalysis: Found C, 57.51; 
H, 8.60; N, 5.88. Calculated for C11H19NO4: C, 57.60; H, 8.34; N, 6.10. 
 
()--Formylmethyl N-Boc-proline methyl ester was prepared from 19 as 
previously described.
7c 
 
(5S) and (5R)-6-Oxo-7-((1’R)-naphthylethyl-)-1,7-diaza-spiro[4.4]nonane-1-
carboxylic acid tert-butyl ester (14a and 14b). 
Prepared from ()--formylmethyl N-Boc-proline methyl ester 19 (0.65 g, 2.4 mmol) 
and (R)-1-(1-naphthyl)ethylamine (0.35ml, 2.50mmol), using the method as 
previously described for 12a and 12b,
7c
 giving a yellow oil (0.75g, 79%). The oil was 
purified on silica gel using 20% ethyl acetate/petroleum ether giving the two 
diastereoisomers. 
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(S,R) Diastereoisomer (14a): Yellow solid, (0.33g, 35%). Rf:  0.50 (60% ethyl 
acetate: petroleum ether). [α]D:  +46.66 (c = 0.75 in MeOH). M.p.:  153-155 
o
C. IR, 
(KBr)/cm
-1
:  3031, 2984, 1685, 1676. 
1
H NMR (two rotamers present) δ:  8.00, 7.81, 
7.50, (3 x m, 7H), 6.13 (q, 1H, J = 7.2 Hz), 3.62-3.45 (m, 3H), 3.27 & 3.08  (2 x t, 1H, 
J = 9.0 Hz), 2.55-2.30 (m, 2H), 2.15-2.05 (m, 2H), 1.98-1.91 (m, 2H), 1.74 (t, 3H, J = 
7.3 Hz), 1.51 & 1.48  (2 x s, 9H). 
13
C NMR (two rotamers present) δ:  173.2, 153.6 & 
153.4,  137.4, 135.6, 133.7, 128.7, 128.5, 126.0, 124.8, 124.1, 123.8, 123.7, 80.2 & 
79.4, 67.6 & 67.5, 48.1 & 48.0, 46.0 & 46.2, 38.8 & 38.3, 36.8 & 36.6, 30.1 & 29.8, 
24.7, 23.3 & 23.1, 16.2 & 15.8.  HRMS (ESI) calculated for C24H31N2O3 [M+H]
+
: 
395.2335. Found: 395.2336. 
 
(R,R) Diastereoisomer (14b): Yellow oil, (0.36g, 38%). Rf:  0.40 (60% ethyl acetate: 
petroleum ether). [α]D:  +40.5 (c = 1 in MeOH). IR, (Thin film)/cm
-1
: 3031, 2986, 
1680, 1676. 
1
H NMR (two rotamers present) δ:  8.61(d, 1H, J = 8.2 Hz), 8.20 (d, 1H, 
J = 8.3 Hz), 7.81 & 7.50, (2 x m, 6H,), 6.27 (q, 0.5H, J = 6.8 Hz), 6.06 (q, 0.5H, J = 
6.8 Hz), 3.69-3.42 (m, 2H), 3.28 (m, 1H), 3.12-2.90 (m, 1H), 2.69 (t, 1H, J = 7.0 Hz), 
2.41-1.67 (m, 5H), 1.63 (d, 3H, J = 7.0 Hz), 1.45 (s, 9H). 
13
C NMR (two rotamers 
present) δ:  173.5, 153.6, 136.5, 135.8, 133.2, 128.6, 128.2, 126.1, 125.0, 124.4, 
123.9, 123.8, 79.8 & 79.4, 68.0 & 67.8, 48.3 & 48.1, 46.5 & 46.2, 38.7 & 38.5, 37.1 
& 36.8, 29.9 & 29.8, 28.6, 22.6 & 22.2, 16.4 & 16.1. HRMS (ESI) calculated for 
C24H31N2O3 [M+H]
+
: 395.2335. Found: 395.2328. 
 
(5S)-6-Oxo-7-((1’R)-naphthylethyl-)-1,7-diaza-spiro[4.4]nonane (15a) 
To a solution of 14a (0.145 g, 0.42 mmol) in DCM (0.3 ml) was added TFA (0.3 ml, 
1.28 mmol), and then stirred at ambient temperature for 16 hr. The solution was then 
concentrated in vacuo, dissolved in H2O (40 ml), and the pH adjusted to ~ 8 by adding 
Et3N dropwise, at 0 
o
C. The product was then extracted with DCM (3 x 20 ml), dried 
over MgSO4, and concentrated in vacuo yielding an oil, which was purified on silica 
gel using 5% MeOH:DCM, giving the product. 
 
(S,R) Diastereoisomer (15a):  yellow oil (0.77g, 90%). Rf:  0.5 (10% MeOH: DCM). 
[α]D:  +8.2 (c = 1.1 in MeOH). IR, (Thin film)/cm
-1
:  3332, 3032, 2995, 1684. 
1
H 
NMR  δ:  7.99-7.96 (m, 1H), 7.88-7.81 (m, 2H), 7.56-7.44 (m, 4H), 6.10 (q, 1H, J = 
7.0 Hz), 3.27-3.22 (m, 1H), 3.12-3.05 (m, 1H), 2.98-2.90 (m, 1H), 2.28-2.22 (m, 1H), 
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1.71-1.93 (m, 7H), 1.68 (d, 3H, J = 7.1 Hz). 
13
C NMR δ:  176.0, 135.1, 133.7, 131.6, 
128.7, 128.6, 128.3, 126.8, 124.9, 124.1, 123.4, 68.1, 47.5, 46.1, 39.1, 35.3, 34.8, 
26.0, 16.1. HRMS (ESI) calculated for C19H23N2O [M+H]
+
: 295.1810. Found: 
295.1801. 
 
(5R)-6-Oxo-7-((1’R)-naphthylethyl-)-1,7-diaza-spiro[4.4]nonane (15b) 
Was prepared from 14b in a similar manner to the preparation of 15a. 
 
(R,R) Diastereoisomer (15b):  yellow oil (0.78g, 92%). Rf:  0.3 (10% MeOH: DCM), 
[α]D:  +11.0 (c = 1 in MeOH). IR, (Thin film)/cm
-1
:  3335, 3030, 2994, 1685. 
1
H 
NMR δ:  8.10-8.01 (m, 0.5H), 7.87-7.81 (m, 0.5H), 7.55-7.48 (m, 2H), 7.46-7.21 (m, 
4H), 6.14 (q, 1H, J = 7.0 Hz), 3.28-3.22 (m, 1H), 3.18-3.05 (m, 1H), 2.98-2.91 (m, 
1H), 2.56-2.45 (m, 1H), 2.14 -1.68 (m, 7H), 1.60 (d, 3H, J = 7.1 Hz). 
13
C NMR δ:  
176.1, 135.1, 133.8, 131.5, 128.8, 128.6, 128.4, 126.8, 125.0, 124.2, 123.6, 68.4, 47.3, 
46.2, 39.1, 35.2, 34.3, 25.8, 16.3. HRMS (ESI) calculated for C19H23N2O [M+H]
+
: 
295.1810. Found: 295.1802. 
 
()-2-Methyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester 
(20)                                    
To a solution of 19 (0.5 g, 2.18 mmol) in dry THF (2 ml) at -20 
o
C, was added a 1.0M 
solution of LiHMDS in THF (3.1 ml, 3.1 mmol) slowly while keeping the temperature 
below -15 
o
C. The solution was stirred for 1.5 hr, under nitrogen, at this temperature. 
Methyl iodide (0.25 ml, 3.1 mmol) was added slowly at -20 
o
C. The solution was 
stirred while allowing it to warm to ambient temperature. After 18 hr the solution was 
quenched with a saturated aqueous solution of NH4Cl (5 ml), extracted with ethyl 
acetate (3 x 20 ml), washed with a brine solution (3 x 10 ml) and then dried over 
MgSO4. The resulting solution was concentrated in vacuo and was purified by column 
chromatography on silica gel, using 10 % ethyl acetate: petroleum ether, giving a 
colourless oil (0.38 g, 72 %). Rf: 0.50 (20 % ethyl acetate: petroleum ether). IR, (Thin 
film)/cm
-1
:  2975, 1750, 1692, 1418. 
1
H NMR (two rotamers present) δ:  3.75 (s, 3H), 
3.70-3.64 (m, 1H), 3.62-3.43 (m, 1H), 2.23-2.05 (m, 1H), 2.04-1.92 (m, 3H), 1.58 (s, 
3H), 1.45 & 1.41 (2 x s, 9H). 
13
C NMR (two rotamers present) δ:  175.4, 153.6, 79.9, 
64.8, 52.1, 47.9, 40.1, 28.2, 23.1, 22.3. 
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()-2-Methyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (21) 
A suspension of 20 (1.25 g, 5.14 mmol) and NaOH (0.204 g, 5.1 mmol) in 
MeOH/H2O (1:1, 20 ml) was heated at reflux temperature for 5 hr. The solvent was 
removed in vacuo, and the residue was partitioned between diethyl ether and H2O 
(1:1, 20 ml). The aqueous phase was then washed with diethyl ether (3 x 10 ml), 
acidified to pH 3 using 1N HCl, followed by extraction with diethyl ether. The ether 
layer was then dried over MgSO4 and concentrated in vacuo yielding the product 
(1.10 g, 93 %), which was used without further purification. Rf:  0.10 (20 % ethyl 
acetate: petroleum ether). M.p.:  91-94 
o
C. IR, (Thin film)/cm
-1
:  2978, 1740, 1648, 
1432. 
1
H NMR (two rotamers present) δ:  3.62-3.42 (m, 2H), 2.60 (m, 1H), 2.45 & 
2.28 (2 x m, 1H), 1.95-1.77 (m, 2H), 1.62 (s, 3H), 1.48 & 1.42 (2 x s, 9H). 
13
C NMR 
(two rotamers present) δ:  176.5, 152.3, 80.6, 66.8, 48.7, 38.4, 28.4, 22.8, 22.2. 
 
2-Methyl-2-[methyl-(1-phenylethyl)-carbamoyl]-pyrrolidine-1-carboxylic acid 
tert-butyl ester (22a and 22b). 
To a stirred solution of 21 (0.45 g, 1.96 mmol) in dry DMF (9 ml) was added DIPEA 
(0.675 ml, 3.92 mmol), followed by (R)-N-methyl--methylbenzyl amine (0.25 ml, 
1.96 mmol) dropwise. After stirring for 5 min. the solution was cooled to 0 
o
C, and a 
solution of HATU (0.752 g, 1.98 mmol) in dry DMF (9 ml) was added slowly. After 
10 min at this temperature, the solution was allowed to warm to ambient temperature 
and stirring was continued for 4 hr. The solution was diluted with EtOAc (200 ml), 
and then washed successively with 10 % HCl solution (3 x 10 ml), saturated aqueous 
sodium carbonate solution (3 x 10 ml), H2O (3 x 10 ml) and brine solution (3 x 10 
ml), and then dried over MgSO4. The solution was concentrated in vacuo giving the 
crude product (0.65 g) which was purified by column chromatography on silica gel in 
10 % ethyl acetate: petroleum ether. 
 
(S,R) Diastereoisomer (22a):  Colourless oil, (0.12 g, 18 %). Rf:  0.7 (40 % ethyl 
acetate: petroleum ether). [α]D:  +8.18 (c = 0.55 in MeOH). IR, (Thin film)/cm
-1
:  
2976, 1686, 1678. 
1
H NMR (two rotamers present) δ:  7.36-7.24 (m, 5H), 6.18-6.11 
(m, 1H), 3.75-3.63 & 3.60-3.52 (2 x m, 1H), 3.38-3.30 (m, 1H), 2.61 & 2.56 (2 x s, 
3H), 2.16-1.96 (m, 4H), 1.59 (s, 3H), 1.56 & 1.52 (2 x s, 3H), 1.48 (s, 9H). 
13
C NMR 
(two rotamers present) δ:  173.0, 153.5, 141.3, 128.5, 127.1 & 126.8, 80.3, 66.2, 51.7, 
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46.7, 38.1, 29.7, 28.3, 24.7, 23.8, 22.1. HRMS (ESI) calculated for C19H29N2O3 
[M+H]
+
: 347.2335. Found: 347.2318. 
 
(R,R) Diastereoisomer (22b):  Colourless oil, (0.21 g, 31 %). Rf:  0.6 (40 % ethyl 
acetate: petroleum ether). [α]D:  +23.9 (c = 0.67 in MeOH). IR, (Thin film)/cm
-1
:  
2972, 1680, 1678. 
1
H NMR (two rotamers present) δ: 7.40-7.26 (m, 5H), 6.21-6.09 
(m, 1H), 3.78-3.62 & 3.59-3.51 (2 x m, 1H), 3.36-3.23 (m, 1H), 2.65 & 2.50 (2 x s, 
3H), 2.25-1.92 (m, 4H), 1.59 & 1.57 (2 x s, 3H), 1.51 & 1.42 (2 x d, J = 1.1 Hz, 3H, 
H), 1.25 & 1.19 (2 x s, 9H). 
13
C NMR (two rotamers present) δ:  172.8, 153.1, 141.6, 
141.4, 128.6, 127.2 & 126.9, 80.1, 66.0, 51.9, 47.2 & 47.0, 38.6 & 38.2, 29.6 & 29.4, 
28.7, 24.7 & 24.5, 23.8 & 23.6, 22.1 & 21.8. HRMS (ESI) calculated for C19H29N2O3 
[M+H]
+
: 347.2335. Found: 347.2325. 
 
The reaction was then conducted using (S)-N-methylbenzyl amine, following the 
method previously described, forming the (R,S) and (S,S) diastereoisomers 22c and 
22d. 
 
(R,S) Diastereoisomer (22c):  Colourless oil, (0.13 g, 19 %). [α]D:  -8.2 (c = 0.55 in 
MeOH). Analytical data is identical to that of the (S,R) diastereoisomer. HRMS (ESI) 
calculated for C19H29N2O3 [M+H]
+
: 347.2335. Found: 347.2320. 
 
 (S,S) Diastereoisomer (22d):  Colourless oil, (0.24 g, 35 %). [α]D:  -24 (c = 0.7 in 
MeOH). Analytical data is identical to that of the (R,R) diastereoisomer. HRMS (ESI) 
calculated for C19H29N2O3 [M+H]
+
: 347.2335. Found: 347.2335. 
 
 
2-Methyl-pyrrolidine-2-carboxylic acid methyl-(1-phenyl-ethyl)-amide (17a-d). 
To a solution of 22(a-d) (0.145 g, 0.42 mmol) in DCM (0.3 ml) was added TFA (0.3 
ml, 1.28 mmol), and it was stirred at ambient temperature for 16 hr. It was then 
concentrated in vacuo, dissolved in H2O (40 ml), and the pH was adjusted to ~ 8 by 
adding Et3N dropwise, at 0 
o
C. It was then extracted with DCM (3 x 20 ml), dried 
over MgSO4, and concentrated in vacuo yielding an oil, which was purified on silica 
gel using 5% MeOH:DCM. 
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(S,R) Diastereoisomer (17a):  Colourless oil, (0.09 g, 88 %). 
Rf:  0.6 (10 % MeOH: DCM). [α]D:  + 18 (c = 1 in MeOH). IR, (Thin film)/cm
-1
:  
3276, 2974, 1676. 
1
H NMR (two rotamers present) δ:  7.40-7.22 (m, 5H), 6.04 & 5.35 
(2 x q, J = 7.0 Hz, 1H), 3.47-3.41 & 3.11-3.02 (2 x m, 2H), 2.74 (s, 3H), 2.30-1.95 
(m, 4H), 1.75 & 1.70 (2 x s, 3H), 1.53 (d, J = 7.1 Hz, 3H). 
13
C NMR (two rotamers 
present) δ: 172.8, 139.4, 129.0, 127.7 & 127.1, 68.3, 52.7, 45.6, 36.2, 30.4, 25.6, 23.9, 
15.2. HRMS (ESI) calculated for C15H23N2O [M+H]
+
: 247.1810. Found: 247.1821. 
 
(R,R) Diastereoisomer (17b):  Colourless oil, (0.092 g, 89 %). Rf:  0.5 (10 % MeOH: 
DCM). [α]D:  + 25 (c = 1 in MeOH). IR, (Thin film)/cm
-1
:  3270, 2976, 1674. 
1
H 
NMR (two rotamers present) δ:  7.36-7.23 (m, 5H), 6.06 & 5.56 (2 x q, J = 7.1 Hz, 
1H), 3.26-3.20 & 3.01-2.92 (2 x m, 2H), 2.76 & 2.70 (2 x s, 3H), 2.17-1.83 (m, 4H), 
1.59 (s, 3H), 1.51 (d, J = 7.0 Hz, 3H). 
13
C NMR (two rotamers present) δ:  174.7, 
130.1, 128.6, 127.4 & 126.3, 66.9, 52.3, 46.2 , 36.6, 30.4, 26.0, 25.6, 15.2. HRMS 
(ESI) calculated for C15H23N2O [M+H]
+
: 247.1810. Found: 247.1810. 
 
(R,S) Diastereoisomer (17c):  Colourless oil, (0.095 g, 92 %). [α]D:  - 18 (c = 1 in 
MeOH). Analytical data is identical to that of the (S,R) diastereoisomer. HRMS (ESI) 
calculated for C15H23N2O [M+H]
+
: 247.1810. Found: 247.1821. 
 
 (S,S) Diastereoisomer (17d):  Colourless oil, (0.095 g, 92 %). [α]D:  - 26 (c = 1 in 
MeOH). Analytical data is identical to that of the (R,R) diastereoisomer. HRMS (ESI) 
calculated for C15H23N2O [M+H]
+
: 247.1810. Found: 247.1808. 
 
 
2-Methyl-2-(1-phenyl-ethylcarbamoyl)-pyrrolidine-1-carboxylic acid tert-butyl 
ester (22e-h). 
To a stirred solution of 21 (0.50 g, 2.18 mmol) in dry DMF (10 ml) was added DIPEA 
(0.75 ml, 4.36 mmol), followed by (R)-1-phenylethylamine (0.29 ml, 2.18 mmol) 
dropwise. After 5 min stirring, the solution was cooled to 0 
o
C, and a solution of 
HATU (0.84 g, 2.2 mmol) in dry DMF (10 ml) was added slowly. After 10 min at this 
temperature, the solution was allowed to warm to ambient temperature and stirring 
was continued for 3 hr. The solution was diluted with EtOAc (200 ml), and then 
washed successively with 10 % HCl (3 x 10 ml), saturated aqueous sodium carbonate 
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solution (3 x 10 ml), H2O (3 x 10 ml) and brine solution (3 x 10 ml), and then dried 
over MgSO4. The solution was concentrated in vacuo yielding a colourless oil (0.70 
g), which was purified by column chromatography on silica gel in 10 % ethyl acetate: 
petroleum ether. 
 
(S,R) Diastereoisomer (22e):  White solid, (0.38 g, 52 %). Rf:  0.70 (40 % ethyl 
acetate: petroleum ether). M.p.: 129-132 
o
C. [α]D:  - 18.6 (c = 0.7 in MeOH). IR, 
(KBr)/cm
-1
:  3305, 2976, 1682, 1671. 
1
H NMR δ:  7.82 (s(br), 1H), 7.32-7.26 (m, 5H), 
5.07 (s(br), 1H), 3.52-3.25 (m(br), 2H), 2.68-2.62 (m(br), 1H), 2.19-2.15 (m(br), 1H), 
1.67-1.70 (m(br), 2H), 1.57 (m(br), 6H), 1.47 (s, 9H). 
13
C NMR δ:  173.7, 152.5, 
129.2, 128.2, 127.1, 48.2, 28.5, 22.4, 18.4. HRMS (ESI) calculated for C19H29N2O3 
[M+H]
+
: 333.2178. Found: 333.2174. 
 
(R,R) Diastereoisomer (22f):  Colourless oil, (0.30 g, 42 %). Rf:  0.60 (40 % ethyl 
acetate: petroleum ether). [α]D:  + 3.8 (c = 0.5 in MeOH). IR, (Thin film)/cm
-1
:   3308, 
2972, 1684, 1672. 
1
H NMR δ: 7.78 (s(br), 1H) 7.33-7.28 (m, 5H), 5.08 (m(br), 1H), 
3.53 (m(br), 2H), 2.66 (m(br), 1H), 2.28 (m(br), 1H), 1.79 (m(br),  2H), 1.58 (m(br), 
6H), 1.46 (s(br), 9H, I). 
13
C NMR (ppm) δ:  173.7, 127.4, 126.3, 125.9, 48.6, 28.2, 
23.4, 22.6. HRMS (ESI) calculated for C19H29N2O3 [M+H]
+
: 333.2178. Found: 
333.2193. 
 
The reaction was then conducted using (S)-(1)-phenylethyl amine, following the 
method previously described, forming the (R,S) and (S,S) diastereoisomers. 
 
(R,S) Diastereoisomer (22g):  White solid, (0.38 g, 52 %). M.p.:  128-131 
o
C. [α]D:  
+ 18.5 (c = 0.7 in MeOH). Other analytical data is identical to that of 22e. HRMS 
(ESI) calculated for C19H29N2O3 [M+H]
+
: 333.2178. Found: 333.2192. 
 
 (S,S) Diastereoisomer (22h):  Colourless oil, (0.30 g, 42 %). [α]D:  - 4.0 (c = 0.5 in 
MeOH). Other analytical data is identical to that of 22f. HRMS (ESI) calculated for 
C19H29N2O3 [M+H]
+
: 333.2178. Found: 333.2180. 
 
 
2-Methyl-pyrrolidine-2-carboxylic acid (1-phenyl-ethyl)-amide (17) 
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To a solution of 22(e-h) (0.2 g, 0.602 mmol) in DCM (0.4 ml) was added TFA (0.4 
ml, 1.7 mmol), and then stirred at ambient temperature for 16 hr. The solution was 
then concentrated in vacuo, dissolved in H2O (40 ml), and the pH adjusted to ~ 8 by 
adding Et3N dropwise, at 0 
o
C. It was then extracted with DCM (3 x 20 ml), dried 
over MgSO4, and concentrated in vacuo yielding an oil, which was purified on silica 
gel in 5% MeOH:DCM. 
 
(S,R) Diastereoisomer (17e):  Yellow solid, (0.14 g, 96 %). Rf:  0.2 (5 % MeOH: 
DCM). M.p.: 100-103 
o
C. [α]D:  + 30.5 (c = 1 in MeOH). IR, (KBr)/cm
-1
:  3414, 3270, 
2974, 1673. 
1
H NMR δ:  8.25 (br. s, 1H), 7.35-7.21 (m, 5H), 5.04 (q, J = 7.1 Hz, 1H), 
3.08-3.03 & 2.83-2.76 (2 x m, 2H), 2.23-2.17 (m, 1H), 1.71-1.53 (m, 3H), 1.46 (d, J = 
6.9 Hz, 3H), 1.43 (s, 3H). 
13
C NMR δ:  178.0, 144.0, 128.5, 126.9, 125.9, 66.6, 48.1, 
47.4, 37.6, 26.5, 25.9, 22.3. HRMS (ESI) calculated for C14H21N2O [M+H]
+
: 
233.1654. Found: 233.1649. 
 
(R,R) Diastereoisomer (17f):  Yellow oil, (0.13 g, 93 %). Rf:  0.2 (5 % MeOH: 
DCM). [α]D
20
:  + 95 (c = 1 in MeOH). IR, (Thin film)/cm
-1
:  3416, 3272, 2976, 1674. 
1
H NMR δ:  8.12 (s (br), 1H), 7.36-7.22 (m, 5H), 5.03 (q, J = 6.9 Hz, 1H), 3.21-3.12 
& 2.96-2.88 (2 x m, 2H), 2.32-2.26 (m, 1H), 1.84-1.63 (m, 3H), 1.47 (d, J = 7.0 Hz, 
3H), 1.44 (s, 3H). 
13
C NMR δ:  175.3, 146.4, 128.6, 127.2, 126.0, 67.1, 48.5, 46.8, 
37.4, 28.5, 26.1, 22.8. HRMS (ESI) calculated for C14H21N2O [M+H]
+
: 233.1654. 
Found: 233.1660. 
 
(R,S) Diastereoisomer (17g):  Yellow solid, (0.133 g, 95 %). M.p.: 106-109 
o
C. [α]D:  
- 30.5 (c = 1 in MeOH).  Other analytical data is identical to that of 17e 
diastereoisomer. HRMS (ESI) calculated for C14H21N2O [M+H]
+
: 233.1654. Found: 
233.1652. 
 
(S,S) Diastereoisomer (17h):  Yellow oil, (0.133 g, 95 %). Rf:  0.2 (5 % MeOH: 
DCM). [α]D:  - 81 (c = 1 %, l = 2 dm, MeOH). Other analytical data is identical to that 
of 17f diastereoisomer. HRMS (ESI) calculated for C14H21N2O [M+H]
+
: 233.1654. 
Found: 233.1647. 
 
Pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (23) 
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A suspension of N-Boc-L-proline methyl ester
7c
 (1.25 g, 5.45 mmol) and NaOH 
(0.216 g, 5.4 mmol) in MeOH/H2O (1:1, 20 ml) was heated at reflux temperature for 5 
hr. The solvent was removed in vacuo, and the residue was dissolved partitioned 
between diethyl ether and H2O (1:1, 20 ml). The aqueous phase was then washed with 
diethyl ether (3 x 10 ml), acidified to pH ~ 3 using 1N HCl, and extracted with diethyl 
ether (20 ml). The ether layer was then dried over MgSO4 and concentrated in vacuo 
giving the product as a white solid (1.15 g, 98 %). It was used without further 
purification. Rf:  0.1 (20 % ethyl acetate: petroleum ether). M.p.: 133-136 
o
C. IR, 
(KBr)/cm
-1
: 2976, 1739, 1639, 1431. 
1
H NMR (two rotamers present) δ:  4.36-4.25 
(m, 1H), 3.52-3.33 (m, 2H), 2.40-2.27 (m, 1H), 2.18-1.88 (m, 3H), 1.50 & 1.43 (2 x s, 
9H). 
13
C NMR (ppm) δ: 177.1, 156.7, 79.8, 67.2, 47.2, 28.3, 28.1, 23.7.  
 
2S-(1’R-Phenyl-ethylcarbamoyl)-pyrrolidine-1-carboxylic acid tert-butyl ester 
(24a) 
To a stirred solution of 23 (0.32 g, 1.50 mmol) in dry DCM (5 ml) was added (R)-1-
phenylethylamine (0.17 ml, 1.50 mmol) dropwise, followed by DMAP (0.183 g, 1.50 
mmol). After 5 min stirring, the solution was cooled to 0 
o
C, and a solution of EDC 
(0.316 g, 1.65 mmol) in dry DCM (5 ml) was added slowly. After 5 min at this 
temperature, the solution was allowed to warm to ambient temperature and stirring 
was continued for 16 hr. The solvent was removed in vacuo and the resulting solid 
was dissolved in EtOAc (30 ml). It was washed successively with H2O (3 x 10 ml), 5 
% HCl solution (3 x 10 ml), saturated aqueous sodium carbonate solution (3 x 10 ml), 
brine (3 x 10 ml) and then dried over MgSO4. It was concentrated in vacuo yielding a 
colorless oil (0.46 g), which was purified by column chromatography on silica gel in 
20 % ethyl acetate: petroleum ether giving a white solid (0.44 g, 90 %). Rf:  0.3 (40 % 
ethyl acetate: petroleum ether). M.p.: 81-84 
o
C. [α]D:  + 38.5 (c = 1 in MeOH). IR, 
(KBr)/cm
-1
:  3304, 2976, 1688, 1676. 
1
H NMR δ:  7.51 (s (br), 1H), 7.31-7.22 (m, 
5H), 5.10 (s (br), 1H), 4.32 (s (br), 1H), 3.34 (s (br), 2H), 2.41 (s (br), 1H), 2.13 (s 
(br), 1H), 1.85 (s (br), 4H), 1.45 (s, 9H). 
13
C NMR δ:  171.3, 155.1, 143.0, 128.6, 
125.9, 47.1, 28.4. Some signals missing due to line broadening.  HRMS (ESI) 
calculated for C18H27N2O3 [M+H]
+
: 319.2022. Found: 319.2015. 
 
2S-(1’S-Phenyl-ethylcarbamoyl)-pyrrolidine-1-carboxylic acid tert-butyl ester 
(24b) 
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Prepared from 21 (0.32 g, 1.50 mmol) in a similar manner to 24a using (R)-1-
phenylethylamine. The crude product was purified by column chromatography on 
silica gel in 20 % ethyl acetate: petroleum ether giving a white solid (0.44 g, 90 %). 
Rf:  0.2 (40 % ethyl acetate: petroleum ether). M.p.: 98-101 
o
C. [α]D:  - 130 (c = 1 in 
MeOH). IR, (KBr)/cm
-1
:  3305, 2977, 1688, 1675. 
1
H NMR δ:  7.51 (s (br), 1H),  
7.31-7.25 (m, 5H), 5.10 (s (br), 1H), 4.33 & 4.25 (2 x m, 1H), 3.35 (s (br), 2H), 2.41 
(s (br), 1H), 2.12 (s (br), 1H), 1.85 (s (br), 5H), 1.46 (s, 9H). 
13
C NMR δ:  171.6, 
154.1, 143.2, 130.7, 128.6, 127.1, 80.5, 48.6, 28.1. HRMS (ESI) calculated for 
C18H27N2O3 [M+H]
+
: 319.2022. Found: 319.2007. 
 
2S-Pyrrolidine-2-carboxylic acid (1’R -phenyl-ethyl)-amide (18a) 
To a solution of 24a (1.0 g, 3.14 mmol) in DCM (2 ml) was added TFA (2 ml, 17 
mmol), and the solution was stirred at ambient temperature for 16 hr. It was then 
concentrated in vacuo, dissolved in H2O (40 ml), and the pH adjusted to ~ 8 by adding 
Et3N dropwise, at 0 
o
C. The product was then extracted with DCM (3 x 20 ml), dried 
over MgSO4, and concentrated in vacuo yielding an oil, which was purified on silica 
gel in 5% MeOH:DCM, giving the product as a yellow oil (0.62 g, 91 %). Rf:  0.5 (10 
% MeOH: DCM). [α]D:  + 21.5 (c = 1 in MeOH). IR, (Thin film)/cm
-1
:  3412, 3263, 
2976, 1672. 
1
H NMR δ:  7.97 (s (br), 1H), 7.35-7.21 (m, 5H), 5.09-5.04 (m, 1H), 
3.91-3.86 (m, 1H), 3.08-2.92 (m, 2H), 2.22-2.10 (m, 1H), 1.93-1.87 (m, 1H), 1.77-
1.70 (m, 2H), 1.47 (d, 3H, J = 7.1 Hz). 
13
C NMR δ:  173.6, 144.8, 128.6, 127.3, 
126.0, 60.3, 49.2, 48.6, 30.6, 25.9, 21.5. HRMS (ESI) calculated for C13H19N2O 
[M+H]
+
: 219.1497. Found: 219.1498. 
 
2S-Pyrrolidine-2-carboxylic acid (1’S-phenyl-ethyl)-amide (18b) 
Prepared from 24b (1.0 g, 3.14 mmol) in a similar manner to 18a to give 18b as a 
yellow oil (0.64 g, 94 %). Rf:  0.4 (10 % MeOH: DCM). [α]D:  - 48 (c = 1 in MeOH). 
IR, (Thin film)/cm
-1
:  3414, 3260, 2977, 1670. 
1
H NMR δ:  8.08 (s (br), 1H), 7.34-
7.20 (m, 5H), 5.30-5.01 (m, 1H), 4.43-4.41 (m, 1H), 3.49-3.10 (m, 2H), 2.38-2.34 (m, 
1H), 1.94-1.86 (m, 3H), 1.48 (d, 3H, J = 7.2 Hz). 
13
C NMR δ:  168.8, 143.1, 128.7, 
127.4, 125.8, 59.5, 50.3, 46.4, 30.2, 24.8, 22.0. HRMS (ESI) calculated for 
C13H19N2O [M+H]
+
: 219.1497. Found: 219.1497. 
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2S-[Methyl-(1’R-phenyl-ethyl)-carbamoyl]-pyrrolidine-1-carboxylic acid tert-
butyl ester (25a) 
To a solution of 24a (0.5 g, 1.57 mmol) in dry THF (5 ml) at -20 
o
C, was added a 
1.0M solution of LiHMDS in THF (1.62 ml, 1.62 mmol) slowly, while keeping the 
temperature below -15 
o
C. The solution was stirred for 30 min., under nitrogen, at this 
temperature. Methyl iodide (0.30 ml, 3.93 mmol) was added slowly at -20 
o
C. The 
solution was stirred while allowing it to warm to ambient temperature. After 18 hr the 
solution was quenched with 1N HCl (20 ml), and the majority (80%) of the solvent 
was removed in vacuo. The remaining suspension was diluted with diethyl ether (40 
ml) and the organic phase was separated, washed with 1N HCl solution (3 x 10 ml), 
saturated aqueous sodium chloride solution (3 x 10 ml), then dried over MgSO4, and 
concentrated in vacuo. The crude product was purified by column chromatography on 
silica gel in 30 % ethyl acetate: petroleum ether giving a yellow oil (0.50 g, 92 %). Rf:  
0.3 (20 % ethyl acetate: petroleum ether). [α]D:  +48.3 (c = 0.6 in MeOH). IR, (Thin 
film)/cm
-1
: 2978, 1697, 1654. 
1
H NMR (two rotamers present) δ:  7.34-7.20 (m, 5H), 
6.15-6.05 (m, 1H), 5.02 & 4.60 (2 x m, 1H), 3.70-3.35 (m, 2H), 2.82 & 2.70 (2 x s, 
3H), 2.12-2.08 (m, 2H), 1.95-1.88 (m, 2H), 1.65 (s, 3H), 1.48 & 1.35 (2 x s, 9H).  
13
C 
NMR (two rotamers present) δ:  173.6, 153.4, 140.3, 128.8, 128.2, 127.0, 56.7, 50.5, 
46.8, 30.6, 29.5, 28.5, 24.4, 15.6. HRMS (ESI) calculated for C19H29N2O3 [M+H]
+
: 
333.2178. Found: 333.2171. 
 
2S-[Methyl-(1’S-phenyl-ethyl)-carbamoyl]-pyrrolidine-1-carboxylic acid tert-
butyl ester (25b) 
Prepared from 24b (0.5 g, 1.57 mmol) in a similar manner to 25a. The crude product 
was purified by column chromatography on silica gel in 30 % ethyl acetate: petroleum 
ether giving a yellow oil (0.52 g, 98 %). Rf:  0.2 (20 % ethyl acetate: petroleum ether). 
[α]D:  -102.3 (c = 0.85 in MeOH). IR, (Thin film)/cm
-1
:  2978, 1696, 1653. 
1
H NMR 
(two rotamers present) δ:  7.34-7.21 (m, 5H), 6.04 (m, 1H), 4.67 & 4.55 (2 x m, 1H), 
3.68-3.45 (m, 2H), 2.73 & 2.68 (2 x s, 3H), 2.08-2.02 (m, 2H), 1.89-1.85 (m, 2H), 
1.58 (s, 3H), 1.48 & 1.45 (2 x s, 9H).  
13
C NMR (two rotamers present) δ:  172.9, 
151.3, 141.6, 128.5, 128.4, 127.2, 57.8, 50.6, 47.1, 29.2, 28.9, 28.5, 23.5, 15.2. HRMS 
(ESI) calculated for C19H29N2O3 [M+H]
+
: 333.2178. Found: 333.2166. 
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2S-Pyrrolidine-2-carboxylic acid methyl-(1’R-phenyl-ethyl)-amide (18c) 
To a solution of 25a (0.3 g, 0.903 mmol) in DCM (0.6 ml) was added TFA (0.6 ml, 
2.6 mmol), and the solution was stirred at ambient temperature for 16 hr. It was 
concentrated in vacuo, dissolved in H2O (40 ml), and the pH was adjusted to ~ 8 by 
adding Et3N dropwise, at 0 
o
C. The product was then extracted with DCM (3 x 20 
ml), dried over MgSO4, and concentrated in vacuo yielding an oil, which was purified 
on silica gel in 5% MeOH:DCM, giving the product as a yellow oil (0.18 g, 86 %). Rf:  
0.6 (10 % MeOH: DCM). [α]D:  + 41 (c = 1 in MeOH). IR, (Thin film)/cm
-1
:  3438, 
2979, 1697, 1655. 
1
H NMR (two rotamers present) δ:  8.10 (d (br), 1H), 7.40-7.22 (m, 
5H), 5.92 (q, 1H, J = 7.1 Hz), 5.30 & 4.74, 3.98 & 3.69 (4 x m, 1H), 3.49-3.39 & 
3.18-2.90 (2 x m, 2H), 2.76 & 2.71 (2 x s, 3H), 2.51-1.58 (m, 4H), 1.50 & 1.47 (2 x d, 
3H, J = 7.1 Hz). 
13
C NMR (two rotamers present) δ:  172.1 & 169.3, 142.8 & 138.5, 
129.1, 128.6, 127.1, 60.3 & 58.1, 52.3 & 48.4, 47.1 & 46.6, 30.6 & 29.7, 25.8 & 25.6, 
22.2, 15.6. HRMS (ESI) calculated for C14H21N2O [M+H]
+
: 233.1654. Found: 
233.1661. 
 
2S-Pyrrolidine-2-carboxylic acid methyl-(1’S-phenyl-ethyl)-amide (18d) 
Prepared from 25b (0.3 g, 0.903 mmol) in a similar manner to 18c to give an oil, 
which was purified on silica gel in 5% MeOH:DCM, giving the product as a yellow 
solid (0.19 g, 88 %). Rf:  0.5 (10 % MeOH:DCM). M.p.: 172-175 
o
C. [α]D: - 120 (c = 
1 in MeOH). IR, (KBr)/cm
-1
:  3436, 2980, 1698, 1650. 
1
H NMR (two rotamers 
present) δ:  7.39-7.21 (m, 5H), 5.93 (q, 1H, J = 7.1 Hz,), 5.05 & 4.84, (2 x m, 1H), 
3.56-3.51 & 3.46-2.38 (2 x m, 2H), 2.69 (s, 3H), 2.54-2.47 (m, 1H), 2.21-2.14 (m, 
1H), 2.08-2.00 (m, 1H), 1.88-1.82 (m, 1H), 1.55 (d, 3H, J = 7.2 Hz). 
13
C NMR (two 
rotamers present) δ:  169.3, 138.8, 129.3, 128.8, 127.2, 58.0, 52.4, 46.7, 29.7, 29.1, 
25.3, 15.2. HRMS (ESI) calculated for C14H21N2O [M+H]
+
: 233.1654. Found: 
233.1655. 
 
General procedure for the Michael Addition reaction of aldehydes and -
nitrostyrene. 
To a solution of the β-nitrostyrene (0.15 g, 1 mmol) in dry DCM (1 ml) was added the 
relevant catalyst (0.05 mmol), followed by the aldehyde (1.5 mmol). The reaction was 
stirred at ambient temperature for 48 or 72 hours, under a nitrogen atmosphere. It was 
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then diluted with chloroform (5 ml) and treated with 1N HCl (4 ml), while stirring 
vigorously. The aqueous layer was extracted with chloroform and the combined 
organic layers were dried over MgSO4 and concentrated in vacuo. The crude product 
was purified by column chromatography on silica gel with 5% EtOAc: petroleum 
ether. For example, 2-propyl-4-nitro-3-phenylbutyraldehyde (16): Rf: 0.6 (20% ethyl 
acetate: petroleum ether). Analytical data was as reported in the literature.
12
 HPLC 
data:  Chiralcel OD-H column; flow 1.6 ml/min using 90/10 hexane/2-propanol, syn tr 
= 6.4 min (S,R) and 8.9 min (R,S), anti tr = 7.6 min and 13.0 min. 
 
X-Ray data 
The data were collected at 150(2)K on a Bruker Apex II CCD diffractometer. The 
structures were solved by direct methods
13,14
 and refined on F
2
 using all the 
reflections.
14
 All the non-hydrogen atoms were refined using anisotropic atomic 
displacement parameters and hydrogen atoms bonded to carbon were inserted at 
calculated positions using a riding model. The H atoms bonded to nitrogen or oxygen 
were located from difference maps and refined with thermal parameters riding on the 
carrier atoms. 
 
Crystal data for 11b. C20H28N2O3, M = 344.44. orthorhombic, a = 6.5297(9), b = 
16.557(2), c = 17.425(3) Å, U = 1883.9(5) Å
3
, T = 150(2) K, space group P212121, Z = 
4, 14987 reflections measured, 1930 independent reflections (Rint = 0.0534). The final 
wR(F2) was 0.0949 (all data) and R1 was 0.0374 for I>2s(I). CCDC No. 687387. 
 
Crystal data for 17b.TsOH. C22H30N2O4S, M = 418.54. orthorhombic, a = 7.8627(11), 
b = 12.6431(18), c = 21.679(3) Å, U = 2155.1(5)  Å
3
, T = 150(2) K, space group 
P212121, Z = 4, 19139 reflections measured, 4406 independent reflections (Rint = 
0.0571) which were used in all calculations.
13
 The final wR(F2) was 0.0812 (all data) 
and R1 was 0.0397 for I>2s(I). CCDC No. 749092. 
 
Crystal data for 22g. C19H28N2O3, M = 332.43. orthorhombic, a = 9.9790(9), b = 
16.6480(15), c = 23.276(2) Å, U = 3866.9(6) Å
3
, T = 150(2) K, space group P212121, 
Z = 8, (two independent molecules in the asymmetric unit), 34133 reflections 
measured, 4427 independent reflections (Rint = 0.0801). The final wR(F2) was 0.0820 
(all data) and R1 was 0.0400 for I>2s(I). CCDC No. 749093. 
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